Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Radiotherapy 3Cisplatin 3Specimen Handling 2Magnetic Resonance Spectroscopy 2Hydroxyurea 2Fluorouracil 2Drug Therapy 2Docetaxel 2Celecoxib 2toripalimab 1antineoplaston AS 2-1 1antineoplaston A10 1X-Rays 1Therapeutics 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Platinum 1Observation 1Nivolumab 1Ipilimumab 1Eucalyptus Oil 1Erlotinib Hydrochloride 1Coal Tar 1Chemoprevention 1Cetuximab 1Carboplatin 1CTLA-4 Antigen 1CP protocol 1Behavior Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paranasal Sinus Neoplasms × Chemoprevention × Head & Neck × Clear all
NCT01469429 2020-02-20

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡